EASL Clinical Practice Guidelines

References

[1]Guyatt, G.H., Oxman, A.D., Vist, G.E., Kunz, R., Falck-Ytter, Y., Alono-Coello, P. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336: 924926
CrossRef | PubMed

[2]Rakoski, M.O., McCammon, R.J., Piette, J.D., Iwashyna, T.J., Marrero, J.A., Lok, A.S. et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012; 55: 184191
CrossRef | PubMed | Scopus (14)

[3]Sherlock, S., Summerskill, W.H.J., White, L.P., and Phear, E.A. Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet. 1954; 264: 453457
Abstract

[4]Fazekas, J.E., Ticktin, H.E., and Shea, J.G. Effects of L-arginine on hepatic encephalopathy. Am J Med Sci. 1957; 234: 462467
CrossRef | PubMed

[5]Kaplan, P.W. and Rossetti, A.O. EEG patterns and imaging correlations in encephalopathy: encephalopathy part II. J Clin Neurophysiol. 2011; 28: 233251
CrossRef | PubMed | Scopus (23)

[6]Conn, H.O. Hepatic encephalopathy. in: L. Schiff, E.R. Schiff (Eds.) Diseases of the liver. 7th ed. Lippincott, Philadelphia, PA; 1993: 10361060

[7]DAmico, G., Morabito, A., Pagliaro, L., and Marubini, E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci. 1986; 31: 468475
CrossRef | PubMed | Scopus (312)

[8]Ding, A., Lee, A., Callender, M., Loughrey, M., Quah, S.P., and Dinsmore, W.W. Hepatic encephalopathy as an unusual late complication of transjugular intrahepatic portosystemic shunt insertion for non-cirrhotic portal hypertension caused by nodular regenerative hyperplasia in an HIV-positive patient on highly active antiretroviral therapy. Int J STD AIDS. 2010; 21: 7172
CrossRef | PubMed | Scopus (6)

[9]Ito, T., Ikeda, N., Watanabe, A., Sue, K., Kakio, T., Mimura, H. et al. Obliteration of portal systemic shunts as therapy for hepatic encephalopathy in patients with non-cirrhotic portal hypertension. Gastroenterol Jpn. 1992; 27: 759764
PubMed

[10]Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., and Blei, A.T. Hepatic encephalopathydefinition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002; 35: 716721
CrossRef | PubMed | Scopus (824)

[11]Cordoba, J. New assessment of hepatic encephalopathy. J Hepatol. 2011; 54: 10301040
Abstract | Full Text | Full Text PDF | PubMed | Scopus (58)

[12]Rikkers, L., Jenko, P., Rudman, D., and Freides, D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology. 1978; 75: 462469
PubMed

[13]Del Piccolo, F., Sacerdoti, D., Amodio, P., Bombonato, G., Bolognesi, M., Mapelli, D. et al. Central nervous system alterations in liver cirrhosis: the role of portal-systemic shunt and portal hypoperfusion. Metab Brain Dis. 2002; 17: 347358
CrossRef | PubMed | Scopus (8)

[14]Bajaj, J.S., Schubert, C.M., Heuman, D.M., Wade, J.B., Gibson, D.P., Topaz, A. et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010; 138: 23322340
Abstract | Full Text | Full Text PDF | PubMed | Scopus (61)

[15]Riggio, O., Ridola, L., Pasquale, C., Nardelli, S., Pentassuglio, I., Moscucci, F. et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011; 9: 181183
Abstract | Full Text | Full Text PDF | PubMed | Scopus (25)

[16]Saunders, J.B., Walters, J.R.F., Davies, P., and Paton, A. A 20-year prospective study of cirrhosis. BMJ. 1981; 282: 263266
CrossRef | PubMed

[17]Romero-Gomez, M., Boza, F., Garcia-Valdecasas, M.S. et al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001; 96: 27182723
CrossRef | PubMed

[18]Jepsen, P., Ott, P., Andersen, P.K., Srensen, H.T., and Vilstrup, H. The clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010; 51: 16751682
CrossRef | PubMed | Scopus (50)

[19]Coltorti, M., Del Vecchio-Blanco, C., Caporaso, N., Gallo, C., and Castellano, L. Liver cirrhosis in Italy. A multicentre study on presenting modalities and the impact on health care resources. National Project on Liver Cirrhosis Group. Ital J Gastroenterol. 1991; 23: 4248
PubMed

[20]Papatheodoridis, G.V., Goulis, J., Leandro, G., Patch, D., and Burroughs, A.K. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology. 1999; 30: 612622
CrossRef | PubMed | Scopus (217)

[21]Nolte, W., Wiltfang, J., Schindler, C., Mnke, H., Unterberg, K., Zumhasch, U. et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology. 1998; 28: 12151225
CrossRef | PubMed | Scopus (80)

[22]Amodio, P., Del Piccolo, F., Petten, E., Mapelli, D., Angeli, P., Iemmolo, R. et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol. 2001; 35: 3745
Abstract | Full Text | Full Text PDF | PubMed | Scopus (93)

[23]Groeneweg, M., Moerland, W., Quero, J.C., Krabbe, P.F., and Schalm, S.W. Screening of subclinical hepatic encephalopathy. J Hepatol. 2000; 32: 748753
Abstract | Full Text | Full Text PDF | PubMed | Scopus (90)

[24]Saxena, N., Bhatia, M., Joshi, Y.K., Garg, P.K., and Tandon, R.K. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J Gastroenterol Hepatol. 2001; 16: 322327
CrossRef | PubMed | Scopus (38)

[25]Schomerus, H. and Hamster, W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis. 2001; 16: 3741
CrossRef | PubMed | Scopus (90)

[26]Sharma, P., Sharma, B.C., Puri, V., and Sarin, S.K. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007; 47: 6773
Abstract | Full Text | Full Text PDF | PubMed | Scopus (69)

[27]Bajaj, J.S. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2008; 2: 785790
CrossRef | PubMed | Scopus (16)

[28]Bustamante, J., Rimola, A., Ventura, P.J., Navasa, M., Cirera, I., Reggiardo, V. et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999; 30: 890895
Abstract | Full Text | Full Text PDF | PubMed | Scopus (224)

[29]Hartmann, I.J., Groeneweg, M., Quero, J.C., Beijeman, S.J., de Man, R.A., Hop, W.C. et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000; 95: 20292034
CrossRef | PubMed

[30]Gentilini, P., Laffi, G., La Villa, G., Romanelli, R.G., Buzzelli, G., Casini-Raggi, V. et al. Long course and prognostic factors of virus-induced cirrhosis of the liver. Am J Gastroenterol. 1997; 92: 6672
PubMed

[31]Benvegno, L., Gios, M., Boccato, S., and Alberti, A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut. 2004; 53: 744749
CrossRef | PubMed | Scopus (272)

[32]Watson, H., Jepsen, P., Wong, F., Gines, P., Cordoba, J., and Vilstrup, H. Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development. Metab Brain Dis. 2013; 28: 301305
CrossRef | PubMed | Scopus (1)

[33]Sharma, B.C., Sharma, P., Agrawal, A., and Sarin, S.K. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose vs. placebo. Gastroenterology. 2009; 137: 885891 ([891.e1])
Abstract | Full Text | Full Text PDF | PubMed | Scopus (86)

[34]Prasad, S., Dhiman, R.K., Duseja, A., Chawla, Y.K., Sharma, A., and Agarwal, R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007; 45: 549559
CrossRef | PubMed | Scopus (200)

[35]Amodio, P., Pellegrini, A., Ubiali, E., Mathy, I., Piccolo, F.D., Orsato, R. et al. The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clin Neurophysiol. 2006; 117: 22432251
Abstract | Full Text | Full Text PDF | PubMed | Scopus (20)

[36]Boyer, T.D. and Haskal, Z.J. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology. 2010; 51: 306
CrossRef | PubMed | Scopus (93)

[37]Riggio, O., Angeloni, S., Salvatori, F.M., De, S.A., Cerini, F., Farcomeni, A. et al. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008; 103: 27382746
CrossRef | PubMed | Scopus (62)

[38]Bai, M., Qi, X., Yang, Z., Yin, Z., Nie, Y., Yuan, S. et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011; 26: 943951
CrossRef | PubMed | Scopus (18)

[39]Spina, G. and Santambrogio, R. The role of portosystemic shunting in the management of portal hypertension. Baillieres Clin Gastroenterol. 1992; 6: 497515
Abstract | Full Text PDF | PubMed | Scopus (4)

[40]Stepanova, M., Mishra, A., Venkatesan, C., and Younossi, Z.M. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol. 2012; 10: 10341041
Abstract | Full Text | Full Text PDF | PubMed | Scopus (18)

[41]Kim, W.R., Brown, R.S. Jr., Terrault, N.A., and El-Serag, H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002; 36: 227242
CrossRef | PubMed | Scopus (302)

[42]Fleming, K.M., Aithal, G.P., Solaymani-Dodaran, M., Card, T.R., and West, J. Incidence and prevalence of cirrhosis in the United Kingdom, 19922001: a general population-based study. J Hepatol. 2008; 49: 732738
Abstract | Full Text | Full Text PDF | PubMed | Scopus (56)

[43]Gitlin, N., Lewis, D.C., and Hinkley, L. The diagnosis and prevalence of sub-clinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol. 1986; 3: 7582
Abstract | Full Text PDF | PubMed

[44]Lockwood, A.H. Whats in a name? Improving the care of cirrhotics. J Hepatol. 2000; 32: 859861
Abstract | Full Text | Full Text PDF | PubMed | Scopus (32)

[45]Amodio, P., Montagnese, S., Gatta, A., and Morgan, M.Y. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis. 2004; 19: 253267
CrossRef | PubMed | Scopus (116)

[46]McCrea, M., Cordoba, J., Vessey, G., Blei, A.T., and Randolph, C. Neuropsycho-logical characterization and detection of subclinical hepatic encephalopathy. Arch Neurol. 1996; 53: 758763
CrossRef | PubMed

[47]Wiltfang, J., Nolte, W., Weissenborn, K., Kornhuber, J., and Ruther, E. Psychiatric aspects of portal-systemic encephalopathy. Metab Brain Dis. 1998; 13: 379389
CrossRef | PubMed | Scopus (15)

[48]Montagnese, S., De Pitta, C., De Rui, M., Corrias, M., Turco, M., Merkel, C. et al. Sleep-wake abnormalities in patients with cirrhosis. Hepatology. 2014; 59: 705712
CrossRef | PubMed | Scopus (1)

[49]Cordoba, J., Cabrera, J., Lataif, L., Penev, P., Zee, P., and Blei, A.T. High prevalence of sleep disturbance in cirrhosis. Hepatology. 1998; 27: 339345
CrossRef | PubMed | Scopus (132)

[50]Montagnese, S., Middleton, B., Skene, D.J., and Morgan, M.Y. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. Liver Int. 2009; 29: 13721382
CrossRef | PubMed | Scopus (16)

[51]Weissenborn, K. Diagnosis of encephalopathy. Digestion. 1998; 59: 2224
CrossRef | PubMed | Scopus (15)

[52]Adams, R.D. and Foley, J.M. The neurological disorder associated with liver disease. Res Publ Assoc Res Nerv Ment Dis. 1953; 32: 198237
PubMed

[53]Cadranel, J.F., Lebiez, E., Di Martino, V., Bernard, B., El Koury, S., Tourbah, A. et al. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?. Am J Gastroenterol. 2001; 96: 515518
CrossRef | PubMed

[54]Delanty, N., French, J.A., Labar, D.R., Pedley, T.A., and Rowan, A.J. Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure. 2001; 10: 116119
Abstract | Full Text PDF | PubMed

[55]Eleftheriadis, N., Fourla, E., Eleftheriadis, D., and Karlovasitou, A. Status epilepticus as a manifestation of hepatic encephalopathy. Acta Neurol Scand. 2003; 107: 142144
CrossRef | PubMed | Scopus (15)

[56]Prabhakar, S. and Bhatia, R. Management of agitation and convulsions in hepatic encephalopathy. Indian J Gastroenterol. 2003; 22: S54S58
PubMed

[57]Weissenborn, K., Bokemeyer, M., Krause, J., Ennen, J., and Ahl, B. Neurological and neuropsychiatric syndromes associated with liver disease. AIDS. 2005; 19: S93S98
CrossRef | PubMed

[58]Read, A.E., Sherlock, S., Laidlaw, J., and Walker, J.G. The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med. 1967; 141: 135150

[59]Baccarani, U., Zola, E., Adani, G.L., Cavalletti, M., Schiff, S., Cagnin, A. et al. Reversal of hepatic myelopathy after liver transplantation: fifteen plus one. Liver Transpl. 2010; 16: 13361337
CrossRef | PubMed | Scopus (5)

[60]Victor, M., Adams, R.D., and Cole, M. The acquired (non Wilsonian) type of chronic hepatocerebral degeneration. Medicine. 1965; 44: 345396
CrossRef | PubMed

[61]Tryc, A.B., Goldbecker, A., Berding, G., Rmke, S., Afshar, K., Shahrezaei, G.H. et al. Cirrhosis-related Parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol. 2013; 58: 698705
Abstract | Full Text | Full Text PDF | PubMed | Scopus (3)

[62]Lee, W.M., Stravitz, R.T., and Larson, A.M. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology. 2012; 55: 965967
CrossRef | PubMed | Scopus (30)

[63]American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Full text. Available at: www.aasld.org/practice-guidelines/Documents/AcuteLiverFailureUpdate2011.pdf.
www.aasld.org/practice-guidelines/Documents/AcuteLiverFailureUpdate2011.pdf

[64]Cordoba, J., Ventura-Cots, M., Simn-Talero, M., Amors, A., Pavesi, M., Vilstrup, H. et al. CANONIC Study Investigators of the EASL-CLIF Consortium. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol. 2014; 60: 275281
Abstract | Full Text | Full Text PDF | PubMed | Scopus (4)

[65]Bajaj, J.S., Wade, J.B., and Sanyal, A.J. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology. 2009; 50: 20142021
CrossRef | PubMed | Scopus (80)

[66]Bajaj, J.S., Cordoba, J., Mullen, K.D., Amodio, P., Shawcross, D.L., Butterrworth, R.F. et al. Review article: the design of clinical trials in hepatic encephalopathyan International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011; 33: 739747
CrossRef | PubMed | Scopus (53)

[67]Montagnese, S., Amodio, P., and Morgan, M.Y. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis. 2004; 19: 281312
CrossRef | PubMed | Scopus (52)

[68]Prakash, R. and Mullen, K.D. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol. 2010; 7: 515525
CrossRef | PubMed | Scopus (68)

[69]Hassanein, T.I., Hilsabeck, R.C., and Perry, W. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig Dis Sci. 2008; 53: 529538
CrossRef | PubMed | Scopus (23)

[70]Guerit, J.M., Amantini, A., Fischer, C., Kaplan, P.W., Mecarelli, O., Schnitzler, A. et al. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009; 29: 789796
CrossRef | PubMed | Scopus (37)

[71]Randolph, C., Hilsabeck, R., Kato, A., Kharbanda, P., Li, Y.Y., Mapelli, D. et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009; 29: 629635
CrossRef | PubMed | Scopus (70)

[72]Lauridsen, M.M., Jepsen, P., and Vilstrup, H. Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis. 2011; 26: 135139
CrossRef | PubMed | Scopus (9)

[73]Bajaj, J.S., Pinkerton, S.D., Sanyal, A.J., and Heuman, D.M. Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology. 2012; 55: 11641171
CrossRef | PubMed | Scopus (24)

[74]Ortiz, M., Jacas, C., and Cordoba, J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005; 42: S45S53
Abstract | Full Text | Full Text PDF | PubMed | Scopus (131)

[75]Bajaj, J.S., Gillevet, P.M., Patel, N.R., Ahluwalia, V., Ridlon, J.M., Kettenmann, B. et al. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab Brain Dis. 2012; 27: 205215
CrossRef | PubMed | Scopus (9)

[76]Weissenborn, K., Ennen, J.C., Schomerus, H., Ruckert, N., and Hecker, H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001; 34: 768773
Abstract | Full Text | Full Text PDF | PubMed | Scopus (301)

[77]Prakash, R.K., Brown, T.A., and Mullen, K.D. Minimal hepatic encephalopathy and driving: is the genie out of the bottle?. Am J Gastroenterol. 2011; 106: 14151416
CrossRef | PubMed | Scopus (7)

[78]Bajaj, J.S., Stein, A.C., and Dubinsky, R.M. What is driving the legal interest in hepatic encephalopathy?. Clin Gastroenterol Hepatol. 2011; 9: 9798
Abstract | Full Text | Full Text PDF | PubMed | Scopus (3)

[79]Dhiman, R.K., Saraswat, V.A., Verma, M., and Naik, S.R. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol. 1995; 10: 1423
CrossRef | PubMed

[80]Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A., and Haussinger, D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002; 35: 357366
CrossRef | PubMed | Scopus (170)

[81]Romero-Gomez, M., Cordoba, J., Jover, R., del Olmo, J.A., Ramirez, M., Rey, R. et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology. 2007; 45: 879885
CrossRef | PubMed | Scopus (124)

[82]Lauridsen, M.M., Thiele, M., Kimer, N., and Vilstrup, H. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis. 2013; 28: 231234
CrossRef | PubMed | Scopus (2)

[83]Bajaj, J.S., Hafeezullah, M., Franco, J., Varma, R.R., Hoffmann, R.G., Knox, J.F. et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008; 135: 15911600
Abstract | Full Text | Full Text PDF | PubMed | Scopus (69)

[84]Bajaj, J.S., Thacker, L.R., Heumann, D.M., Fuchs, M., Sterling, R.K., Sanyal, A.J. et al. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology. 2013; 58: 11221132
CrossRef | PubMed | Scopus (11)

[85]Amodio, P., Del Piccolo, F., Marchetti, P., Angeli, P., Iemmolo, R., Caregaro, L. et al. Clinical features and survival of cirrhotic patients with sub-clinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999; 29: 16621667
CrossRef | PubMed | Scopus (138)

[86]Montagnese, S., Biancardi, A., Schiff, S., Carraro, P., Carla, V., Mannaioni, G. et al. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology. 2010; 53: 558566
CrossRef | Scopus (21)

[87]Lockwood, A.H. Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis. 2004; 19: 345349
CrossRef | PubMed | Scopus (45)

[88]Grnbaek, H., Johnsen, S.P., Jepsen, P., Gislum, M., Vilstrup, H., Tage-Jensen, U. et al. Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study. BMC Gastroenterol. 2008; 8: 16
CrossRef | PubMed | Scopus (13)

[89]Strauss, E., Tramote, R., Silva, E.P., Caly, W.R., Honain, N.Z., Maffei, R.A. et al. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology. 1992; 39: 542545
PubMed

[90]Als-Nielsen, B., Gluud, L.L., and Gluud, C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ. 2004; 328: 1046
CrossRef | PubMed

[91]Riggio, O., Varriale, M., Testore, G.P., Di Rosa, R., Di Rosa, E., Merli, M. et al. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. J Clin Gastroenterol. 1990; 12: 433436
CrossRef | PubMed

[92]Huang, E., Esrailian, E., and Spiegel, B.M. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathya decision analysis. Aliment Pharmacol Ther. 2007; 26: 11471161
CrossRef | PubMed | Scopus (30)

[93]Camma, C., Fiorello, F., Tine, F., Marchesini, G., Fabbri, A., and Pagliaro, L. Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis. Dig Dis Sci. 1993; 38: 916922
CrossRef | PubMed

[94]Morgan, M.Y., Hawley, K.E., and Stambuk, D. Lactitol vs. lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. J Hepatol. 1987; 4: 236244
Abstract | Full Text PDF | PubMed

[95]Uribe, M., Berthier, J.M., Lewis, H., Mata, J.M., Sierra, J.G., Garca-Ramos, G. et al. Lactose enemas plus placebo tablets vs. neomycin tablets plus starch enemas in acute portal systemic encephalopathy. A double-blind randomized controlled study. Gastroenterology. 1981; 81: 101106
PubMed

[96]Uribe, M., Campollo, O., Vargas, F., Ravelli, G.P., Mundo, F., Zapata, L. et al. Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial. Hepatology. 1987; 7: 639643
CrossRef | PubMed

[97]Rahimi, R.S., Singal, A.G., Cuthbert, J.A., and Rockey, D.G. A randomized trial of polyethylene glycol 3350-electrolyte solution (PEG) and lactulose for patients hospitalized with acute hepatic encephalopathy. Hepatology. 2012; 56: 915A916A ([abstr. 1546])

[98]Conn, H.O. and Lieberthal, M.M. The hepatic coma syndromes and lactulose. Williams and Wilkins, Baltimore, MA; 1979

[99]Bajaj, J.S., Sanyal, A.J., Bell, D., Gilles, H., and Heuman, D.M. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther. 2010; 31: 10121017
CrossRef | PubMed | Scopus (70)

[100]Patidar, K.R. and Bajaj, J.S. Antibiotics for the treatment of hepatic encephalopathy. Metab Brain Dis. 2013; 28: 307312
CrossRef | PubMed | Scopus (5)

[101]Bass, N.M., Mullen, K.D., Sanyal, A., Poordad, F., Neff, G., Leevy, C.B. et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010; 362: 10711081
CrossRef | PubMed | Scopus (276)

[102]Gluud, L.L., Dam, G., Borre, M., Les, I., Cordoba, J., Marchesini, G. et al. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?. Metab Brain Dis. 2013; 28: 221225
CrossRef | PubMed | Scopus (15)

[103]Ventura-Cots, M., Arranz, J.A., Simόn-Talero, M., Torrens, M., Blanco, A., Riudor, E. et al. Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study. J Clin Gastroenterol. 2013; 47: 881887
CrossRef | PubMed | Scopus (7)

[104]Rockey, D.C., Vierling, J.M., Mantry, P., Ghabril, M., Brown, R.S. Jr., Alexeeva, O. et al. HALT-HE Study Group. Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology. 2014; 59: 10731083
CrossRef | PubMed | Scopus (5)

[105]Kircheis, G., Nilius, R., Held, C., Berndt, H., Buchner, M., Gortelmeyer, R. et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology. 1997; 25: 13511360
CrossRef | PubMed | Scopus (190)

[106]Agrawal, A., Sharma, B.C., Sharma, P., and Sarin, S.K. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol. 2012; 107: 10431050
CrossRef | PubMed | Scopus (24)

[107]Hawkins, R.A., Jessy, J., Mans, A.M., Chedid, A., and DeJoseph, M.R. Neomycin reduces the intestinal production of ammonia from glutamine. Adv Exp Med Biol. 1994; 368: 125134
CrossRef | PubMed

[108]Morgan, M.H., Read, A.E., and Speller, D.C. Treatment of hepatic encephalopathy with metronidazole. Gut. 1982; 23: 17
CrossRef | PubMed

[109]Simn-Talero, M., Garca-Martnez, R., Torrens, M., Augustin, S., Gmez, S., Pereira, G. et al. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol. 2013; 59: 11841192
Abstract | Full Text | Full Text PDF | PubMed | Scopus (8)

[110]Sharma, P., Agrawal, A., Sharma, B.C., and Sarin, S.K. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose vs. no lactulose. J Gastroenterol Hepatol. 2011; 26: 9961003
CrossRef | PubMed | Scopus (16)

[111]Riggio, O., Masini, A., Efrati, C., Nicolao, F., Angeloni, S., Salvatori, F.M. et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol. 2005; 42: 674679
Abstract | Full Text | Full Text PDF | PubMed | Scopus (61)

[112]Fanelli, F., Salvatori, F.M., Rabuffi, P., Boatta, E., Riggio, O., Lucatelli, P. et al. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. AJR Am J Roentgenol. 2009; 193: 16961702
CrossRef | PubMed | Scopus (12)

[113]Chung, H.H., Razavi, M.K., Sze, D.Y., Frisoli, J.K., Kee, S.T., Dake, M.D. et al. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?. J Gastroenterol Hepatol. 2008; 23: 95101
CrossRef | PubMed | Scopus (11)

[114]Laleman, W., Simon-Talero, M., Maleux, G., Perez, M., Ameloot, K., Soriano, G...., and on behalf of the EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multi-center survey on safety and efficacy. Hepatology. 2013; 57: 24482457
CrossRef | PubMed | Scopus (18)

[115]Sharma, P., Sharma, B.C., Agrawal, A., and Sarin, S.K. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose vs. no lactulose. J Gastroenterol Hepatol. 2012; 27: 13291335
CrossRef | PubMed | Scopus (19)

[116]Sidhu, S.S., Goyal, O., Mishra, B.P., Sood, A., Chhina, R.S., and Soni, R.K. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol. 2011; 106: 307316
CrossRef | PubMed | Scopus (68)

[117]Bajaj, J.S., Heuman, D.M., Wade, J.B., Gibson, D.P., Saeian, K., Wegelin, J.A. et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology. 2011; 140: 478487
Abstract | Full Text | Full Text PDF | PubMed | Scopus (56)

[118]Bajaj, J.S., Saeian, K., Christensen, K.M., Hafeezullah, M., Varma, R.R., Franco, J. et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008; 103: 17071715
CrossRef | PubMed | Scopus (93)

[119]Mittal, V.V., Sharma, B.C., Sharma, P., and Sarin, S.K. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2011; 23: 725732
CrossRef | PubMed | Scopus (27)

[120]Saji, S., Kumar, S., and Thomas, V. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy. Trop Gastroenterol. 2011; 32: 128132
PubMed

[121]Shukla, S., Shukla, A., Mehboob, S., and Guha, S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther. 2011; 33: 662671
CrossRef | PubMed | Scopus (38)

[122]Amodio, P., Bemeur, C., Butterworth, R., Cordoba, J., Kata, A., Montagnese, S. et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: ISHEN practice guidelines. Hepatology. 2013; 58: 325336
CrossRef | PubMed | Scopus (13)

[123]Montano-Loza, A.J., Meza-Junco, J., Prado, C.M., Lieffers, J.R., Baracos, V.E., Bain, V.G. et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012; 10: 166173
Abstract | Full Text | Full Text PDF | PubMed | Scopus (54)

[124]Tandon, P., Ney, M., Irwin, I., Ma, M.M., Gramlich, L., Bain, V.G. et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012; 18: 12091216
CrossRef | PubMed | Scopus (22)

[125]Tsien, C.D., McCullough, A.J., and Dasarathy, S. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol. 2012; 27: 430441
CrossRef | PubMed | Scopus (19)

[126]Ndraha, S., Hasan, I., and Simadibrata, M. The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. Acta Med Indones. 2011; 43: 1822
PubMed

[127]Naylor, C.D., ORourke, K., Detsky, A.S., and Baker, J.P. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology. 1989; 97: 10331042
PubMed

[128]Marchesini, G., Bianchi, G., Merli, M., Amodio, P., Panella, C., Loguercio, C. et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology. 2003; 124: 17921801
Abstract | Full Text | Full Text PDF | PubMed | Scopus (280)

[129]Marchesini, G., Marzocchi, R., Noia, M., and Bianchi, G. Branched-chain amino acid supplementation in patients with liver diseases. J Nutr. 2005; 135: 1596S1601S
PubMed

[130]Gluud, L.L., Dam, G., Borre, M., Les, I., Cordoba, J., Marchesini, G. et al. Oral branched chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials. J Nutr. 2013; 143: 12631268
CrossRef | PubMed | Scopus (8)

[131]Martin, P., DiMartini, A., Feng, S., Brown, R. Jr., and Fallon, M. Evaluation for liver transplantation in adults: 2013 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014; 59: 11441165
CrossRef | PubMed | Scopus (2)

[132]Lucey, M.R., Terrault, N., Ojo, L., Hay, J.E., Neuberger, J., Blumberg, E. et al. Long-term management of the successful adult liver transplant: 2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013; 19: 326
CrossRef | PubMed | Scopus (28)

[133]Herrero, J.I., Bilbao, J.I., Diaz, M.L., Alegre, F., Inarrairaegui, M., Pardo, F. et al. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: treatment with embolization of portosystemic collaterals. Liver Transpl. 2009; 15: 111114
CrossRef | PubMed | Scopus (8)

[134]Chavarria, L., Alonso, J., Garca-Martnez, R., Simn-Talero, M., Ventura-Cots, M., Ramrez, C. et al. Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy. J Cereb Blood Flow Metab. 2013; 33: 272277
CrossRef | PubMed | Scopus (4)

[135]Garcia-Martinez, R., Rovira, A., Alonso, J., Jacas, C., Simn-Talero, M., Chavarria, L. et al. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume. Liver Transpl. 2011; 17: 3846
CrossRef | PubMed | Scopus (27)

[136]Amodio, P., Biancardi, A., Montagnese, S., Angeli, P., Iannizzi, P., Cillo, U. et al. Neurological complications after orthotopic liver transplantation. Dig Liver Dis. 2007; 39: 740747
Abstract | Full Text | Full Text PDF | PubMed | Scopus (27)

[137]Poordad, F.F. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007; 25: 39
CrossRef | PubMed | Scopus (86)

[138]Bajaj, J.S., Wade, J.B., Gibson, D.P., Heuman, D.M., Thacker, L.R., Sterling, R.K. et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011; 106: 16461653
CrossRef | PubMed | Scopus (26)

[139]Neff, G.W., Kemmer, N., Zacharias, V.C., Kaiser, T., Duncan, C., McHenry, R. et al. Analysis of hospitalizations comparing rifaximin vs. lactulose in the management of hepatic encephalopathy. Transplant Proc. 2006; 38: 35523555
Abstract | Full Text | Full Text PDF | PubMed | Scopus (43)

[140]Guevara, M., Baccaro, M.E., Torre, A., Gmez-Ansn, B., Ros, J., Torres, F. et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol. 2009; 104: 13821389
CrossRef | PubMed | Scopus (74)

[141]Guevara, M., Baccaro, M.E., Ros, J., Martn-Llah, M., Uriz, J., Ruiz del Arbol, L. et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration. Liver Int. 2010; 30: 11371142
CrossRef | PubMed | Scopus (21)

[142]Angeli, P., Wong, F., Watson, H., and Gines, P. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology. 2006; 44: 15351542
CrossRef | PubMed | Scopus (149)

[143]Sharma, P., Sharma, B.C., and Sarin, S.K. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int. 2009; 29: 13651371
CrossRef | PubMed | Scopus (15)

[144]Sigal, S.H., Stanca, C.M., Kontorinis, N., Bodian, C., and Ryan, E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol. 2006; 101: 14901496
CrossRef | PubMed | Scopus (34)

[145]Kalaitzakis, E., Olsson, R., Henfridsson, P., Hugosson, I., Bengtsson, M., Jalan, R. et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int. 2007; 27: 11941201
PubMed

[146]Kalaitzakis, E. and Bjornsson, E. Renal function and cognitive impairment in patients with liver cirrhosis. Scand J Gastroenterol. 2007; 42: 12381244
CrossRef | PubMed | Scopus (10)

[147]Gustot, T., Durand, F., Lebrec, D., Vincent, J.L., and Moreau, R. Severe sepsis in cirrhosis. Hepatology. 2009; 50: 20222032
CrossRef | PubMed | Scopus (103)

[148]Young, G.B., Bolton, C.F., Austin, T.W., Archibald, Y.M., Gonder, J., and Wells, G.A. The encephalopathy associated with septic illness. Clin Invest Med. 1990; 13: 297304
PubMed

[149]Butterworth, R.F. Thiamine deficiency-related brain dysfunction in chronic liver failure. Metab Brain Dis. 2009; 24: 189196
CrossRef | PubMed | Scopus (23)

[150]Pitel, A.L., Beaunieux, H., Witkowski, T., Vabret, F., Guillery-Girard, B., Quinette, P. et al. Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence. Alcohol Clin Exp Res. 2007; 31: 11691178
CrossRef | PubMed | Scopus (46)

[151]Noel, X., Van der Linden, M., Schmidt, N., Sferrazza, R., Hanak, C., Le Bon, O. et al. Supervisory attentional system in nonamnestic alcoholic men. Arch Gen Psychiatry. 2001; 58: 11521158
CrossRef | PubMed

[152]Dawson, L.K. and Grant, I. Alcoholics initial organizational and problem-solving skills predict learning and memory performance on the Rey-Osterrieth Complex Figure. J Int Neuropsychol Soc. 2000; 6: 1219
CrossRef | PubMed | Scopus (14)

[153]Sullivan, E.V., Rosenbloom, M.J., and Pfefferbaum, A. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res. 2000; 24: 611621
CrossRef | PubMed

[154]Pitel, A.L., Zahr, N.M., Jackson, K., Sassoon, S.A., Rosenbloom, M.J., Pfefferbaum, A. et al. Signs of preclinical Wernickes encephalopathy and thiamine levels as predictors of neuropsychological deficits in alcoholism without Korsakoffs syndrome. Neuropsychopharmacology. 2011; 36: 580588
CrossRef | PubMed | Scopus (18)

[155]Laskus, T., Radkowski, M., Bednarska, A., Wilkinson, J., Adair, D., Nowicki, M. et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002; 76: 1006410068
CrossRef | PubMed | Scopus (94)

[156]Forton, D.M., Karayianni, P., Mahmud, N., Taylor-Robinson, S.D., and Thomas, H.C. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol. 2004; 78: 51705183
CrossRef | PubMed | Scopus (140)

[157]Fishman, S.L., Murray, J.M., Eng, F.J., Walewski, J.L., Morgello, S., and Branch, A.D. Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis. 2008; 197: 597607
CrossRef | PubMed | Scopus (38)

[158]Wilkinson, J., Radkowski, M., and Laskus, T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol. 2009; 83: 13121319
CrossRef | PubMed | Scopus (70)

[159]Poynard, T., Cacoub, P., Ratziu, V., Myers, R.P., Dezailles, M.H., Mercadier, A. et al. For the Multivirc Group. Fatigue in patients with chronic hepatitis C. J Viral Hepat. 2002; 9: 295303
CrossRef | PubMed | Scopus (113)

[160]Hassoun, Z., Willems, B., Deslauriers, J., Nguyen, B.N., and Huet, P.M. Assessment of fatigue in patients with chronic hepatitis C using the fatigue impact scale. Dig Dis Sci. 2002; 47: 26742681
CrossRef | PubMed | Scopus (38)

[161]Forton, D.M., Thomas, H.C., Murphy, C.A., Allsop, J.M., Foster, G.R., Main, J. et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002; 35: 433439
CrossRef | PubMed | Scopus (252)

[162]Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schler, A., Ennen, J.C. et al. Hepatitis C virus infection affects the brainevidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol. 2004; 41: 845851
Abstract | Full Text | Full Text PDF | PubMed | Scopus (126)

[163]Tarter, R.E., Hegedus, A.M., Van Thiel, D.H., Edwards, N., and Schade, R.R. Neurobehavioral correlates of cholestatic and hepatocellular disease: dif ferentiation according to disease specific characteristics and severity of the identified cerebral dysfunction. Int J Neurosci. 1987; 32: 901910
CrossRef | PubMed

[164]Tarter, R.E., Hays, A.L., Carra, J., Edwards, K.L., and Van Thiel, D.H. Sjogrens syndrome. Its contribution to neuropsychiatric syndrome in patients with primary biliary cirrhosis. Dig Dis Sci. 1989; 34: 912
CrossRef | PubMed | Scopus (6)

[165]Newton, J.L., Hollingsworth, K.G., Taylor, R., El-Sharkawy, A.M., Khan, Z.U., Pearce, R. et al. Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology. Hepatology. 2008; 48: 541549
CrossRef | PubMed | Scopus (29)

[166]Jacoby, A., Rannard, A., Buck, D., Bhala, N., Newton, J.L., James, O.F.W. et al. Development, validation and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut. 2005; 54: 16221629
CrossRef | PubMed | Scopus (59)

[167]Newton, J.L., Bhala, N., Burt, J., and Jones, D.E.J. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol. 2006; 44: 776782
Abstract | Full Text | Full Text PDF | PubMed | Scopus (49)

[168]Newton, J.L., Gibson, J.G., Tomlinson, M., Wilton, K., and Jones, D.E.J. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology. 2006; 44: 9198
CrossRef | PubMed | Scopus (67)

[169]Teasdale, G. and Jennett, B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974; 2: 8184
Abstract | PubMed